Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:14:24 +0200Wed, 22 May 2024 16:22:00 +0200Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/flixabiHuman medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/flixabiWed, 22 May 2024 16:22:00 +0200Human medicineFlixabi : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4020-steps-after_en_1.pdfFlixabi : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4020-steps-after_en_1.pdfWed, 22 May 2024 13:04:00 +0200Human medicine